Corrigendum to “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model.” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531](S0939-6411(19)30181-X)(10.1016/J.Ejpb.2019.02.005)

Corrigendum to “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model.” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531](S0939-6411(19)30181-X)(10.1016/J.Ejpb.2019.02.005) Publisher Pubmed

Alibolandi M¹ ; Sadeghi F^{2, 3} ; Abnous K⁴ ; Atyabi F⁵ ; Ramezani M^{4, 6} ; Hadizadeh F¹

Show Affiliations

1. Biotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
2. Targeted Drug Delivery Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
3. Department of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Scienecs, Mashhad, Iran
4. Pharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
5. Nanothechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Mashhad, Iran
6. Nanothechnology Research Center, Scool of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Source: European Journal of Pharmaceutics and Biopharmaceutics Published:2019

Abstract

Style	Citing Format
MLA	Alibolandi M, et al.. "Corrigendum to “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model.” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531](S0939-6411(19)30181-X)(10.1016/J.Ejpb.2019.02.005)." European Journal of Pharmaceutics and Biopharmaceutics, vol. 142, no. , 2019, pp. 540-.
APA	Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F (2019). Corrigendum to “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model.” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531](S0939-6411(19)30181-X)(10.1016/J.Ejpb.2019.02.005). European Journal of Pharmaceutics and Biopharmaceutics, 142(), 540-.
Chicago	Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F. "Corrigendum to “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model.” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531](S0939-6411(19)30181-X)(10.1016/J.Ejpb.2019.02.005)." European Journal of Pharmaceutics and Biopharmaceutics 142, no. (2019): 540-.
Harvard	Alibolandi M et al. (2019) 'Corrigendum to “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model.” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531](S0939-6411(19)30181-X)(10.1016/J.Ejpb.2019.02.005)', European Journal of Pharmaceutics and Biopharmaceutics, 142(), pp. 540-.
Vancouver	Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F. Corrigendum to “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model.” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531](S0939-6411(19)30181-X)(10.1016/J.Ejpb.2019.02.005). European Journal of Pharmaceutics and Biopharmaceutics. 2019;142():540-.
BibTex	@article{ author = {Alibolandi M and Sadeghi F and Abnous K and Atyabi F and Ramezani M and Hadizadeh F}, title = {Corrigendum to “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model.” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531](S0939-6411(19)30181-X)(10.1016/J.Ejpb.2019.02.005)}, journal = {European Journal of Pharmaceutics and Biopharmaceutics}, volume = {142}, number = {}, pages = {540-}, year = {2019} }
RIS	TY - JOUR AU - Alibolandi M AU - Sadeghi F AU - Abnous K AU - Atyabi F AU - Ramezani M AU - Hadizadeh F TI - Corrigendum to “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model.” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531](S0939-6411(19)30181-X)(10.1016/J.Ejpb.2019.02.005) JO - European Journal of Pharmaceutics and Biopharmaceutics VL - 142 IS - SP - 540 EP - PY - 2019 ER -

Style

Citing Format

MLA

Alibolandi M, et al.. "Corrigendum to “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model.” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531](S0939-6411(19)30181-X)(10.1016/J.Ejpb.2019.02.005)." European Journal of Pharmaceutics and Biopharmaceutics, vol. 142, no. , 2019, pp. 540-.

APA

Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F (2019). Corrigendum to “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model.” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531](S0939-6411(19)30181-X)(10.1016/J.Ejpb.2019.02.005). European Journal of Pharmaceutics and Biopharmaceutics, 142(), 540-.

Chicago

Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F. "Corrigendum to “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model.” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531](S0939-6411(19)30181-X)(10.1016/J.Ejpb.2019.02.005)." European Journal of Pharmaceutics and Biopharmaceutics 142, no. (2019): 540-.

Harvard

Alibolandi M et al. (2019) 'Corrigendum to “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model.” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531](S0939-6411(19)30181-X)(10.1016/J.Ejpb.2019.02.005)', European Journal of Pharmaceutics and Biopharmaceutics, 142(), pp. 540-.

Vancouver

Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F. Corrigendum to “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model.” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531](S0939-6411(19)30181-X)(10.1016/J.Ejpb.2019.02.005). European Journal of Pharmaceutics and Biopharmaceutics. 2019;142():540-.

BibTex

@article{ author = {Alibolandi M and Sadeghi F and Abnous K and Atyabi F and Ramezani M and Hadizadeh F}, title = {Corrigendum to “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model.” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531](S0939-6411(19)30181-X)(10.1016/J.Ejpb.2019.02.005)}, journal = {European Journal of Pharmaceutics and Biopharmaceutics}, volume = {142}, number = {}, pages = {540-}, year = {2019} }

RIS

TY - JOUR
AU - Alibolandi M
AU - Sadeghi F
AU - Abnous K
AU - Atyabi F
AU - Ramezani M
AU - Hadizadeh F
TI - Corrigendum to “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model.” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531](S0939-6411(19)30181-X)(10.1016/J.Ejpb.2019.02.005)
JO - European Journal of Pharmaceutics and Biopharmaceutics
VL - 142
IS -
SP - 540
EP -
PY - 2019
ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract